Compare DraftKings Inc (DKNG) vs Kenvue Inc. Common Stock (KVUE) Price & Performance

DraftKings IncTrade

Kenvue Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

DraftKings Inc vs Kenvue Inc. Common Stock — how do they compare? DraftKings Inc trades at $19.5 (market cap $9.86B), while Kenvue Inc. Common Stock trades at $17.7 (market cap $34.06B). The key difference: Kenvue Inc. Common Stock is far larger — about 3.5× DraftKings Inc's market cap, and Kenvue Inc. Common Stock pays a 4.74% dividend while DraftKings Inc pays none. Which is the better fit depends on your goals.

	DKNG	KVUE
Market Cap	$9.86B	$34.06B
Volume	16,584,596	23,267,228
Sector	Consumer Cyclical	Consumer Staples
52-Week High	$36.24	$19.83
52-Week Low	$18.59	$14.11
Typical Hold Time	55 Days	—
Enterprise Value	$10.80B	$41.56B
Dividend Yield	—	4.74%

View details →View details →

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

DraftKings Inc

DraftKings (DKNG) trades at $19.15, down 3.04% and near its 52-week low of $18.95. The stock is technically bearish with weak moving averages, though RSI indicates potential oversold conditions. Fundamentally, revenue grew to $6.05B in 2025 with a slight net profit of $3.71M, but recent quarters show earnings misses. The company is investing in prediction markets and maintains a $1B EBITDA target for 2026.

Despite a high valuation (P/E 246.33) and recent price decline, 75% of analysts rate DKNG a Buy with a $33.13 consensus target. Key risks include competitive pressure, regulatory uncertainty, and the stock's sensitivity to growth expectations. The path to sustained profitability and margin expansion remains critical for investor confidence.

Kenvue Inc. Common Stock

No Aura AI signal available yet.

Aura AI is an analytical signal, not financial advice — do your own research.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

DKNG

DraftKings shares drop 19% in a month; Bank of America upgrades to Buy, signaling a possible bottom.24/7 Wall Street · 1 day agoNeutral BofA upgrades DraftKings to 'Buy' citing growth in prediction markets and 45% upside potential.Proactive Investors · 4 days agoBullish Nasdaq hits record high driven by growth stocks despite cautious Dow and rising long-term yieldsFXEmpire · 4 days agoBullish View details →

KVUE

Investor buys Kenvue for steady dividends amid Wall Street's tech market worries24/7 Wall Street · 1 day agoBullish View details →

About DraftKings Inc

DraftKings Inc is a digital sports entertainment and gaming company. The company provides users with daily fantasy sports (DFS), sports betting, and iGaming opportunities and is also involved in the design & development of sports betting and casino gaming platform software for online and retail sportsbook and casino gaming products. It operates in two segments: Business-to-consumer(B2C) and Business-to-Business(B2B), of which the vast majority of its revenue comes from the B2C segment. Geographically, it derives most of its revenue from the United States.

About Kenvue Inc. Common Stock

Kenvue is a consumer health company that markets personal care, self-care, and skin health products. Its brands include Tylenol, Listerine, Neutrogena, Johnson’s, BAND-AID Brand, Aveeno, and Zyrtec.